DJIA 17,356.87 288.00 1.69%
NASDAQ 4,644.31 96.48 2.12%
S&P 500 2,012.89 40.15 2.04%
market minute promo

Baxter International (NYSE: BAX)



company name or ticker
Company Photos
(Click to zoom)

Dividend Income Update - October 2014

Momenta Pharmaceuticals, Inc. Pushes Forward

With just $4.7 million from sales of enoxaparin in the third quarter, investors have to be focused on the pipeline.

Trade-Ideas: Baxter International (BAX) Is Today's "Barbarian At The Gate" Stock

Baxter International Gets FDA Nod for Hemophilia A Drug - Analyst Blog

Baxter International Gets FDA Nod for Hemophilia A Drug - Analyst Blog

Baxter Deal Justifies The Potential Of Merrimack's MM-398

CORRECTED-UPDATE 1-Baxter's blood disorder drug gets FDA approval (Oct 24)

UPDATE 1-Baxter's blood disorder drug gets FDA approval

Baxter's blood disorder drug gets FDA approval

3 Biotech Stocks Near 52-Week Highs Worth Selling

Three Motley Fool analysts weigh in on which stocks they think should be sold near their highs.

Baxter International Shows Stability on Top Line - Analyst Blog

See More Articles...